DailySpaceAdvance Information Marketing Berhad
0122 · ACE Market创业板（ACE Market） · annual reports 2022 to 2025, 1073 entries read2022 至 2025 年报，共读出 1073 条
The company这家公司
Advance Information Marketing provides managed customer loyalty services and retails pharmaceutical products. The latest report describes its services business as business process outsourcing, or BPO. Its operations include Malaysia and Indonesia.Advance Information Marketing 提供客户忠诚度管理服务，并零售药品。最新年报把服务业务称为业务流程外包，即 BPO。业务涵盖马来西亚与印度尼西亚。
Source: annual report 2022, page 96; annual report 2025, pages 62, 122.出处：2022 年年报第 96 页；2025 年年报第 62、122 页。
The first CONSTANT PHARMACY outlet in Bukit Raja, Klang began operating towards the end of the fourth quarter of 2022. It ceased operating in May 2024. The 2025 report says seven Medix retail outlets opened across Klang Valley in 2025.首家 CONSTANT PHARMACY 门店位于 Klang 的 Bukit Raja，于 2022 年第四季度末开始营业，并于 2024 年 5 月停业。2025 年报表示，2025 年在 Klang Valley 开设了七家 Medix 零售门店。
Source: annual report 2022, page 11; annual report 2025, pages 4, 10.出处：2022 年年报第 11 页；2025 年年报第 4、10 页。
For the 18-month period ended 30 June 2025, external revenue comprised RM3.7 million from services and RM4.0 million from pharmacy retail. Malaysia contributed RM6.4 million and Indonesia RM1.3 million. The major-customer note records RM1.3 million from Customer A and RM511,695 from Customer B, both under managed customer loyalty services.截至 2025 年 6 月 30 日的 18 个月期间，外部营业额包括服务业务的 RM3.7 million 和药品零售的 RM4.0 million。马来西亚贡献 RM6.4 million，印度尼西亚贡献 RM1.3 million。主要客户附注列出 Customer A 的 RM1.3 million 和 Customer B 的 RM511,695，两者均属于客户忠诚度管理服务。
Source: annual report 2025, pages 10, 67, 120, 122.出处：2025 年年报第 10、67、120、122 页。
The 2023 substantial-shareholder table listed Mak Siew Wei with 95,657,888 shares, or 24.51%. In the 2025 largest-holder list, M & A NOMINEE (TEMPATAN) SDN. BHD. - EXEMPT AN FOR SFGHK LIMITED (ACCOUNT CLIENT) held 74,120,787 shares, or 18.99%; AFFIN HWANG NOMINEES (TEMPATAN) SDN. BHD. - EXEMPT AN FOR LAZARUS SECURITIES PTY LTD held 36,000,000 shares, or 9.23%; and JADI CHEMICALS SDN. BHD. held 19,500,000 shares, or 5.00%.2023 年主要股东表列出 Mak Siew Wei 持有 95,657,888 股，占 24.51%。2025 年最大股东名单中，M & A NOMINEE (TEMPATAN) SDN. BHD. - EXEMPT AN FOR SFGHK LIMITED (ACCOUNT CLIENT) 持有 74,120,787 股，占 18.99%；AFFIN HWANG NOMINEES (TEMPATAN) SDN. BHD. - EXEMPT AN FOR LAZARUS SECURITIES PTY LTD 持有 36,000,000 股，占 9.23%；JADI CHEMICALS SDN. BHD. 持有 19,500,000 股，占 5.00%。
Source: annual report 2023, page 127; annual report 2025, page 137.出处：2023 年年报第 127 页；2025 年年报第 137 页。
The 2025 list also includes pledged securities accounts: KENANGA NOMINEES (TEMPATAN) SDN. BHD. for TAN POW CHOO @ WONG SENG ENG, 10,940,700 shares (2.80%); M & A NOMINEE (TEMPATAN) SDN. BHD. for LOW PENG SIAN @ CHUA PENG SIAN (M&A), 10,000,000 (2.56%); HLIB NOMINEES (TEMPATAN) SDN. BHD. for NG KIM GUAN (CCTS), 1,469,900 (0.38%); and MAYBANK NOMINEES (TEMPATAN) SDN. BHD. for WONG INN LAI, 1,388,008 (0.36%).2025 年名单也列有质押证券账户：KENANGA NOMINEES (TEMPATAN) SDN. BHD. 为 TAN POW CHOO @ WONG SENG ENG 持有 10,940,700 股（2.80%）；M & A NOMINEE (TEMPATAN) SDN. BHD. 为 LOW PENG SIAN @ CHUA PENG SIAN (M&A) 持有 10,000,000 股（2.56%）；HLIB NOMINEES (TEMPATAN) SDN. BHD. 为 NG KIM GUAN (CCTS) 持有 1,469,900 股（0.38%）；MAYBANK NOMINEES (TEMPATAN) SDN. BHD. 为 WONG INN LAI 持有 1,388,008 股（0.36%）。
Source: annual report 2025, page 137.出处：2025 年年报第 137 页。
Chou Sing Hoan became Executive Director on 17 March 2025. Dato’ Lim Choo Hooi and Noorliza Binti Ismail became Independent Non-Executive Directors on the same date; Wong Foo Sim and Dr. Lo Zhen Hao joined in those roles on 30 April 2025. The Chairman position remained vacant after Dato’ Ir. Lim Siang Chai resigned on 17 March 2025. The report states that none of the directors has a family relationship with a director or major shareholder.Chou Sing Hoan 于 2025 年 3 月 17 日出任执行董事。Dato’ Lim Choo Hooi 和 Noorliza Binti Ismail 同日出任独立非执行董事；Wong Foo Sim 和 Dr. Lo Zhen Hao 于 2025 年 4 月 30 日出任相同职务。Dato’ Ir. Lim Siang Chai 于 2025 年 3 月 17 日辞职后，主席职位仍然空缺。年报表示，各董事与任何董事或主要股东均无亲属关系。
Source: annual report 2025, pages 8, 44, 46.出处：2025 年年报第 8、44、46 页。
External revenue by business, 18 months ended June 2025截至 2025 年 6 月的 18 个月各业务外部营业额
Source: annual report 2025, pages 109, 120.出处：2025 年年报第 109、120 页。
Revenue by country, 18 months ended June 2025截至 2025 年 6 月的 18 个月各国营业额
Source: annual report 2025, page 122.出处：2025 年年报第 122 页。
Major events大事记
Source: annual report 2022, pages 11, 85.出处：2022 年年报第 11、85 页。
Source: annual report 2022, page 118.出处：2022 年年报第 118 页。
Source: annual report 2023, page 41.出处：2023 年年报第 41 页。
Source: annual report 2023, page 41.出处：2023 年年报第 41 页。
Source: annual report 2023, page 42.出处：2023 年年报第 42 页。
Source: annual report 2023, page 124.出处：2023 年年报第 124 页。
Source: annual report 2025, page 10.出处：2025 年年报第 10 页。
Source: annual report 2025, page 64.出处：2025 年年报第 64 页。
Source: annual report 2025, page 46.出处：2025 年年报第 46 页。
Source: annual report 2025, page 4.出处：2025 年年报第 4 页。
Source: annual report 2025, page 134.出处：2025 年年报第 134 页。
Revenue, loss and operating cash; 2025 covers 18 months营业额、亏损与营运现金；2025 年涵盖 18 个月
Assets, bank borrowings and equity资产、银行借款与权益
20222022 年
Operations used RM3.6 million of cash. Investing activities brought in RM2.1 million, including RM1.3 million released from deposits and RM1.0 million from redeeming a money market fund. Cash purchases of property, plant and equipment were RM199,938, and intangible assets RM72,889. The group repaid RM666,802 of loans and RM23,824 of lease liabilities. No dividend was paid or declared.营运活动使用 RM3.6 million 现金。投资活动带来 RM2.1 million，包括收回存款 RM1.3 million，以及赎回货币市场基金 RM1.0 million。现金购置产业、厂房与设备支出为 RM199,938，无形资产支出为 RM72,889。集团偿还贷款 RM666,802 和租赁负债 RM23,824。公司没有支付或宣派股息。
Source: annual report 2022, pages 42, 56, 57.出处：2022 年年报第 42、56、57 页。
20232023 年
Operations brought in RM2.9 million of cash. A private placement raised RM2.0 million and the rights issue raised RM23.4 million. The group placed RM20.8 million in money market funds and redeemed RM1.0 million. Property, plant and equipment purchases were RM12,855. Loan repayments were RM64,559 and lease repayments RM62,050. Excess rights subscriptions of RM7.7 million remained payable at year end and were refunded in January 2024. No dividend was proposed, declared or paid.营运活动带来 RM2.9 million 现金。私下配售筹得 RM2.0 million，附加股发行筹得 RM23.4 million。集团投入货币市场基金 RM20.8 million，并赎回 RM1.0 million。购置产业、厂房与设备支出为 RM12,855。偿还贷款 RM64,559 和租赁负债 RM62,050。年末仍须退还的附加股超额认购款为 RM7.7 million，已于 2024 年 1 月退还。公司没有建议、宣派或支付股息。
Source: annual report 2023, pages 44, 57, 60, 101.出处：2023 年年报第 44、57、60、101 页。
2025: 18 months ended 30 June2025 年：截至 6 月 30 日的 18 个月
Operations used RM22.1 million of cash. The group redeemed RM21.0 million from money market funds and placed RM1.0 million in them. It spent RM6.4 million on property, plant and equipment and RM350,000 on intangible assets. Loan repayments were RM115,471 and lease repayments RM355,907. There were no share issues or dividends during the period. Cash and bank balances ended at RM209,227; cash and cash equivalents were negative RM303,949.营运活动使用 RM22.1 million 现金。集团赎回货币市场基金 RM21.0 million，并投入 RM1.0 million。产业、厂房与设备支出为 RM6.4 million，无形资产支出为 RM350,000。偿还贷款 RM115,471 和租赁负债 RM355,907。期间没有发行股份或派发股息。期末现金与银行结余为 RM209,227；现金与现金等价物为负 RM303,949。
Source: annual report 2025, pages 67, 81, 82.出处：2025 年年报第 67、81、82 页。
Across the years各年合看
The group recorded losses of RM4.4 million in 2022, RM4.7 million in 2023 and RM11.1 million in the latest 18-month period. Bank borrowings were RM1.5 million, RM2.0 million and RM1.9 million at the respective reporting dates. The latest period also included RM1.8 million of property, plant and equipment written off and RM345,000 of intangible assets written off. The parent company recognised RM18.7 million of impairment losses on amounts due from subsidiaries.集团在 2022 年录得 RM4.4 million 亏损，2023 年为 RM4.7 million，最新的 18 个月期间为 RM11.1 million。各报告期末的银行借款分别为 RM1.5 million、RM2.0 million 和 RM1.9 million。最新期间也注销了 RM1.8 million 的产业、厂房与设备，以及 RM345,000 的无形资产。母公司就子公司欠款确认 RM18.7 million 减值损失。
Source: annual report 2025, pages 67, 80, 102.出处：2025 年年报第 67、80、102 页。
Still to be spent尚待使用的资金
The latest proceeds table reports the RM23.4 million rights issue proceeds as fully used. RM970,000 of private-placement proceeds remained. The board approved reallocating this balance from IT equipment and systems upgrades to working capital for Angkara Setia Development Sdn Bhd on 7 February 2025, with a revised utilisation period of 12 months.最新募集资金表列出，RM23.4 million 附加股发行款已全部使用。私下配售款仍剩 RM970,000。董事会于 2025 年 2 月 7 日批准把这笔余额由升级资讯科技设备与系统，改用于 Angkara Setia Development Sdn Bhd 的营运资金，修订后的使用期限为 12 个月。
Source: annual report 2025, pages 64, 65.出处：2025 年年报第 64、65 页。
Four years of figures四年数字
Group figures, in RM, as printed in the statements.集团数字，单位令吉，照财务报表所印。
| Group集团 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|
| RM令吉 | RM令吉 | RM令吉 | RM令吉 | |
| Revenue营业额 | 7,751,671 | 3,438,165 | 3,528,650 | 7,657,465 |
| Loss before tax税前亏损 | (5,187,104) | (4,433,571) | (4,746,693) | (11,099,357) |
| Loss for the year or period年度或期间亏损 | (5,161,551) | (4,442,604) | (4,742,815) | (11,107,509) |
| Net cash from operating activities营运活动所得现金净额 | (3,064,907) | (3,583,545) | 2,945,773 | (22,124,053) |
| Purchase of property, plant and equipment购置产业、厂房与设备 | (29,349) | (199,938) | (12,855) | (6,420,658) |
| Total assets总资产 | 15,739,513 | 11,372,060 | 40,633,008 | 20,915,536 |
| Bank borrowings银行借款 | 2,204,131 | 1,537,329 | 2,006,077 | 1,870,475 |
| Cash and bank balances现金与银行结余 | 2,765,389 | 566,952 | 9,592,317 | 209,227 |
| Cash and cash equivalents现金与现金等价物 | 2,765,389 | 566,952 | 9,059,010 | (303,949) |
| Total equity总权益 | 12,526,849 | 8,704,703 | 29,864,228 | 16,248,666 |
| Other investments其他投资 | 3,482,616 | 4,137,400 | 3,155,224 | 574,012 |
On a computer, hover over a figure for the report and page it is printed on.在电脑上把鼠标移到数字上，可看到它印在哪份年报的哪一页。
Said and done说过的与做到的
| What the reports said年报说要做的 | What later reports show之后年报显示的 | Status状态 |
|---|---|---|
| The 2022 report expected the Indonesian subsidiary's contribution to grow in 2023.2022 年报预期印度尼西亚子公司的贡献会在 2023 年增长。 | Indonesian revenue fell from RM2.8 million in 2022 to RM1.7 million in 2023.印度尼西亚营业额由 2022 年的 RM2.8 million 降至 2023 年的 RM1.7 million。 Source: annual report 2022, page 11; annual report 2023, page 111.出处：2022 年年报第 11 页；2023 年年报第 111 页。 | Revenue fell营业额下降 |
| The 2022 report said efforts were underway to reduce reliance on the Indonesian subsidiary through pharmaceutical retail.2022 年报表示，正通过药品零售业务减少对印度尼西亚子公司的依赖。 | The latest report records seven operating pharmacy outlets at 30 June 2025. Pharmacy external revenue was RM4.0 million in the 18-month period, while Indonesian revenue was RM1.3 million.最新年报记载，截至 2025 年 6 月 30 日有七家药房门店营业。该 18 个月期间的药房外部营业额为 RM4.0 million，印度尼西亚营业额为 RM1.3 million。 Source: annual report 2022, page 10; annual report 2025, pages 10, 67, 120, 122.出处：2022 年年报第 10 页；2025 年年报第 10、67、120、122 页。 | Pharmacy business expanded药房业务已扩展 |
| The private-placement plan allocated RM1.0 million to IT equipment and systems upgrades, to be used within 24 months of listing.私下配售计划拨出 RM1.0 million 升级资讯科技设备与系统，拟于上市后 24 个月内使用。 | The latest table records RM47,000 used for upgrades. The remaining RM970,000 was reallocated to working capital, with board approval on 7 February 2025.最新表格列出升级用途已使用 RM47,000。余下 RM970,000 改拨为营运资金，董事会于 2025 年 2 月 7 日批准。 Source: annual report 2022, page 40; annual report 2025, page 64.出处：2022 年年报第 40 页；2025 年年报第 64 页。 | Plan changed; balance reallocated计划已改变；余额已改拨 |
| The 2023 rights-issue plan allocated RM16.0 million to pharmacy working capital, to be used within 24 months of listing.2023 年附加股发行计划拨出 RM16.0 million 作为药房营运资金，拟于上市后 24 个月内使用。 | The latest report records the pharmacy working-capital allocation as fully used.最新年报列出，药房营运资金拨款已全部使用。 Source: annual report 2023, page 42; annual report 2025, page 65.出处：2023 年年报第 42 页；2025 年年报第 65 页。 | Reported fully used报告已全部使用 |
What the reports leave open年报留下待看的事
- The auditors draw attention to a material uncertainty related to going concern at the parent company. Its loss was RM22.0 million, with current liabilities exceeding current assets by RM617,645 and total liabilities exceeding total assets by RM40,481.审计师提请注意母公司持续经营方面的重大不确定性。母公司亏损 RM22.0 million，流动负债超过流动资产 RM617,645，总负债超过总资产 RM40,481。
Source: annual report 2025, pages 72, 83.出处：2025 年年报第 72、83 页。
- Refundable deposits of RM5.0 million relate to digital property and renovation works at the group's office building.RM5.0 million 可退还押金涉及集团办公楼的数字产业及装修工程。
Source: annual report 2025, page 101.出处：2025 年年报第 101 页。
- The latest report plans further pharmacy expansion and expects better contributions in 2026 from more outlets coming into operation.最新年报计划继续扩展药房业务，并预期更多门店投入营业会在 2026 年带来更高贡献。
Source: annual report 2025, pages 10, 12.出处：2025 年年报第 10、12 页。
- The Chairman position remained vacant, and the company said it was looking for a suitable candidate.主席职位仍然空缺，公司表示正在寻找合适人选。
Source: annual report 2025, page 44.出处：2025 年年报第 44 页。
Facts as printed in the company's annual reports, with the page of each; no rating and no advice. Built 2026-10-28.内容为公司年报所印的事实，并注明页码；不评级，不构成投资建议。生成日期 2026-10-28。